ReviewNature nanotechnology2025
Nanosensors for real-time intracellular analytics.
Review in Nature nanotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Neuromorphic Devices and Computing for Sensing, Memory, and Control.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- A fluorous-phase oxygen optical nanosensor for mitigating redox-active microbial metabolite interference.The Analyst · 2026Article
- Research and application advances in real-time single-cell functional analysis.Discover nano · 2026Review
- Dose as a fundamental organizing principle in physiology: Implications for mechanism, disease, and precision medicine.Journal of precision medicine (Amsterdam, Netherlands) · 2026Article
- Bioelectronics forNanotheranostics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
A fundamental goal in modern biology and precision medicine is to acquire rich, multi-omics-style information from cells, including transcriptomic, proteomic, metabolic and electrophysiological data, in real time and at single-cell resolution. However, current techniques often rely on destructive endpoint assays that require cell lysis, losing spatial, temporal and dynamic context. Nanoscale sensors offer a transformative solution by enabling minimally invasive, continuous monitoring of intracellular activities. Here we propose a spatial classification of intracellular sensing technologies-near cell, on cell and in cell-and use this framework to evaluate the sensing modalities on the basis of their invasiveness, signal fidelity and resolution. We highlight emerging sensor platforms that are capable of detecting ions, metabolites, electrical signals and mechanical changes, as well as artificial intelligence-driven strategies for decoding complex cellular data streams. We further consider the integration of these nanosensors into three-dimensional, physiologically relevant models such as organoids to create 'smart organoids' that report on their internal state autonomously and in real time. Finally, we discuss the major challenges in achieving intelligent intracellular sensing, including issues of sensor miniaturization, biocompatibility, multiplexing and three-dimensional integration. Together, these advances set the stage for a new era of dynamic, high-resolution cell profiling that can accelerate drug discovery, disease modelling and personalized medicine.
Indexed as
Identifiers
41094263What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.